rheumatoid arthritis

Latest Headlines

Latest Headlines

Bioelectronics startup begins trial to treat Crohn's after early success in RA

SetPoint Medical is starting a clinical trial to treat Crohn's disease patients with its implantable neuromodulation device. The startup previously reported a positive pilot study of the device to treat rheumatoid arthritis.

Quest scientists and others identify new rheumatoid arthritis biomarker

Researchers have identified a new biomarker for rheumatoid arthritis that could help with earlier diagnosis and treatment.

Biomarker could improve early rheumatoid arthritis diagnosis

A novel biomarker could make it easier for physicians to diagnose rheumatoid arthritis early, thereby improving patients' prospects. The best results come when conventional antibody testing is combined with the new biomarker.

Myriad/Crescendo's rheumatoid arthritis test shows viability in new trial

Myriad Genetics paid $270 million for Crescendo Bioscience in February, and now a new study affirms the clinical viability of Crescendo's Vectra DA, a protein-based test designed to assess a patient's rheumatoid arthritis disease progression and activity.

Inova picks up rheumatoid arthritis biomarkers from Dutch university

Inova Diagnostics once again has its sights on rheumatoid arthritis-detecting technology, this week acquiring a novel platform developed at Hasselt University designed to identify autoantibody biomarkers for the debilitating condition.

Booming Regeneron adds to R&D footprint in NY

With sales of eye drug Eylea growing at breakneck pace and a couple of promising candidates in its pipeline, Regeneron needs some more space.

Top 10 rheumatoid arthritis drugs 2013

Humira is the world's best-selling drug, bringing in $9.6 billion last year. The way drug information specialist EvaluatePharma sees it, AbbVie's ($ABBV) gem is going to remain the...

J&J's Simponi Aria approved for RA as it heads for blockbuster stratosphere

The FDA has approved Simponi in combination with methotrexate to treat moderately to severely active rheumatoid arthritis. The company points out that an estimated 1.3 million Americans and more than 23.5 million people worldwide suffer from RA. 

Crescendo Bioscience achieves Medicare coverage for RA Dx

Crescendo Bioscience won Medicare coverage for its rheumatoid arthritis molecular diagnostic, a major milestone and pivotal move in its bid to expand the test's market reach.

Cheaper generic combo found as effective in RA as blockbuster Enbrel

Amgen was delivered a nasty surprise about its superblockbuster Enbrel this week when a new study found that a cocktail of generics already on the market was as effective at treating rheumatoid arthritis.